Patents Assigned to Zinc Therapeutics Canada, Inc.
  • Zinc ionophores as therapeutic agents
    Patent number: 6689774
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: February 10, 2004
    Assignee: Zinc Therapeutics, Canada Inc.
    Inventor: Henry Fliss
  • Zinc ionophores as therapeutic agents
    Patent number: 6495538
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for protecting tissue from the harmful effects of apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: December 17, 2002
    Assignee: Zinc Therapeutics, Canada Inc.
    Inventor: Henry Fliss
  • Zinc ionophores as anti-apoptotic agents
    Patent number: 6407090
    Abstract: The present invention provides methods and compositions comprising one or more zinc ionophores for blocking apoptosis in patients in need thereof. Concentrations of zinc-pyrithione and diethyldithiocarbamate in the picomolar to nanomolar range have a strong protective effect against apoptosis.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: June 18, 2002
    Assignee: Zinc Therapeutics Canada, Inc.
    Inventor: Henry Fliss